These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7991851)

  • 21. Efficacy of vaginal use of topical estriol in postmenopausal women with urogenital atrophy.
    Chuery AC; Speck NM; de Moura KF; Belfort PN; Sakano C; Ribalta JC
    Clin Exp Obstet Gynecol; 2011; 38(2):143-5. PubMed ID: 21793275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen treatment of postmenopausal vaginal atrophy--a cytological assessment.
    Hustin J; Drykoningen GJ
    Maturitas; 1979 Feb; 1(3):207-13. PubMed ID: 502878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
    Al-Baghdadi O; Ewies AA
    Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of raloxifene on sexual function in postmenopausal women.
    Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A
    Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of menopausal symptoms--review of the current literature].
    Magyar Z; Fél T
    Orv Hetil; 2006 May; 147(19):879-85. PubMed ID: 16784143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal women.
    Bachmann GA; Schaefers M; Uddin A; Utian WH
    Menopause; 2009; 16(5):877-82. PubMed ID: 19458560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practice observed.
    Gray S
    Menopause Int; 2010 Dec; 16(4):169-70. PubMed ID: 21156855
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women.
    Simon JA; Reape KZ; Wininger S; Hait H
    Fertil Steril; 2008 Oct; 90(4):1132-8. PubMed ID: 18053998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experimental investigation of the effects of estriol on menopausal symptoms (author's transl)].
    Martius G; Horchler KH
    Geburtshilfe Frauenheilkd; 1975 Dec; 35(12):938-43. PubMed ID: 1213259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy for the treatment of vaginal atrophy.
    Donders GGG; Ruban K; Bellen G; Grinceviciene S
    Expert Opin Pharmacother; 2019 May; 20(7):821-835. PubMed ID: 30897020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estriol: safety and efficacy.
    Head KA
    Altern Med Rev; 1998 Apr; 3(2):101-13. PubMed ID: 9577246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New local therapy of atrophic vaginitis].
    Lieveaux A
    Gynecol Prat; 1972; 23(4):193-5. PubMed ID: 4197031
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of estradiol valerate and levonorgestrel on vaginal health.
    Manonai J; Chittacharoen A; Theppisai U
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):190-3. PubMed ID: 15262354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transvaginal administration of estriol in postmenopausal urogynecological disorders].
    Di Stefano L; Patacchiola F; Moscarini M
    Minerva Ginecol; 1993 Nov; 45(11):551-6. PubMed ID: 8121603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections.
    Ozkinay E; Terek MC; Yayci M; Kaiser R; Grob P; Tuncay G
    BJOG; 2005 Feb; 112(2):234-40. PubMed ID: 15663590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective estrogen receptor modulators and vulvovaginal atrophy: can we improve the lives of our patients with new therapeutic options?
    Shulman LP
    Menopause; 2010; 17(3):452-3. PubMed ID: 20464782
    [No Abstract]   [Full Text] [Related]  

  • 38. [Colpocytological and urocytological modifications induced by estriol in menopausal women].
    Perretti F
    Minerva Ginecol; 1967 Jun; 19(12):647-52. PubMed ID: 5611226
    [No Abstract]   [Full Text] [Related]  

  • 39. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
    Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intravaginal treatment of colpitis maculosa with an oestriol-containing vaginal cream (author's transl)].
    Schröck A; Kofler K; Baumgarten K; Endl J; Schmidt J; Tatschl S
    Wien Klin Wochenschr; 1981 Dec; 93(23):713-6. PubMed ID: 7342467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.